Literature DB >> 24826003

Simultaneous Determination of Ofloxacin and Flavoxate Hydrochloride by Absorption Ratio and Second Derivative UV Spectrophotometry.

Mahesh Attimarad1.   

Abstract

The objective of this study was to develop simple, precise, accurate and sensitive UV spectrophotometric methods for the simultaneous determination of ofloxacin (OFX) and flavoxate HCl (FLX) in pharmaceutical formulations. The first method is based on absorption ratio method, by formation of Q absorbance equation at 289 nm (λmax of OFX) and 322.4 nm (isoabsorptive point). The linearity range was found to be 1 to 30 μg/ml for FLX and OFX. In the method-II second derivative absorption at 311.4 nm for OFX (zero crossing for FLX) and at 246.2 nm for FLX (zero crossing for OFX) was used for the determination of the drugs and the linearity range was found to be 2 to 30 μg/ml for OFX and 2-75 μg /ml for FLX. The accuracy and precision of the methods were determined and validated statistically. Both the methods showed good reproducibility and recovery with % RSD less than 1.5%. Both the methods were found to be rapid, specific, precise and accurate and can be successfully applied for the routine analysis of OFX and FLX in combined dosage form.

Entities:  

Keywords:  Spectrophotometery; Validation; absorption ratio; flavoxate HCl; ofloxacin; second derivative

Year:  2011        PMID: 24826003      PMCID: PMC3979210     

Source DB:  PubMed          Journal:  J Basic Clin Pharm        ISSN: 0976-0113


  2 in total

1.  Simultaneous Determination of Moxifloxacin and Flavoxate by RP-HPLC and Ecofriendly Derivative Spectrophotometry Methods in Formulations.

Authors:  Mahesh Attimarad; Muhammad Shahzad Chohan; Abdulmalek Ahmed Balgoname
Journal:  Int J Environ Res Public Health       Date:  2019-04-03       Impact factor: 3.390

2.  A conventional HPLC-MS method for the simultaneous determination of ofloxacin and cefixime in plasma: Development and validation.

Authors:  Mahesh V Attimarad; Ahmed O Alnajjar
Journal:  J Basic Clin Pharm       Date:  2013-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.